We apologize your item could not be found. Not all items are listed on our website. Please contact your account manager for details regarding your searched item.
Material number (eg: xxxxxxxxxxx) no space or hyphen needed.
No Results Found
West hosted a dedication ceremony on September 17 to mark the start-up of its recently completed compression molding plant in the Shanghai Zhangjiang High-Tech Industrial Development Zone Qingpu Park in China. The new plant is adjacent to West’s injection molding facility.
The 11,900-square-meter compression molding plant manufactures components used for packaging injectable drugs, supplying customers primarily in China and the Asia-Pacific region. Construction began in June 2011.
“West is experiencing an exciting period of growth in the Asia-Pacific region and we are proud to complete our second manufacturing facility in China,” said Donald E. Morel, Jr., West’s Chairman and Chief Executive Officer. “This facility will provide better service to our customers, offering shorter lead times for delivery of our world-class pharmaceutical packaging products and creating new, flexible capacity to meet the growing demands for our products in China and throughout the Asia-Pacific region. Our investment in this new facility demonstrates our commitment to and confidence in the China market.
“On behalf of West’s Board of Directors and our employees worldwide, I would like to thank representatives of the Chinese government and the Shanghai Zhangjiang High-Tech Industrial Development Zone Qingpu Park, in particular, for their continued support throughout the construction of the new facility.”
“The Project Team for this facility includes representatives from our global team in China, Germany and Singapore, reflecting the strength and reach of our business,” said Warwick Bedwell, President, Asia-Pacific Region. “This plant continues our global expansion plans and is a perfect complement to the injection molding plant already established in Qingpu. Our talented management team in China has worked hard to fulfill this important business objective that will further fuel our business growth. I thank the commitment and teamwork displayed by all our West colleagues who worked on this project. It was truly an exceptional global effort.”
<span style="color: windowtext;">West</span> is pleased to announce the launch of its 10th annual West without Borders fundraising campaign!
West is pleased to announce that its Online Store now offers the ability to request some of West’s elastomeric testing services! In addition to some of West’s highest quality products available ready-to-use in convenient small packs, USP/EP Combined Chemical and Functional testing on elastomers is now available for purchase on the Online Store. Additionally, shoppers who complete a purchase online are granted automatic customer-level access to the newly redesigned West Knowledge Center, offering in-depth technical content and support.
In 2004, Camp Victory, which is located in Millville, Pennsylvania, and operates camps for children who live with chronic health disadvantages including spina bifida, autism and cancer, added a wheel-chair friendly treehouse to their “Wish List” of needs. The tree house came with a hefty price tag and for several years, it sat on the list untouched. Just when Camp Victory was about to remove the treehouse from the wish list, it received a call from West’s CEO Don Morel and the campaign to build “Uncle Walt’s Treehouse” was born.
Lyophilization (freeze drying) is the process of dehydrating a material at low temperature and reduced pressure. It is used to extend the shelf life of many biologic drug products. Absent water, degradation processes are greatly reduced. In any primary package system (i.e., vial, elastomer stopper, seal) for a lyophilized drug product, of utmost concern are leachables and volatile organic compounds that may migrate from the elastomer stopper into the lyophilized drug product, creating a risk to patient safety.
When it comes to filing time, the last thing you need is a surprise. The pharmaceutical industry focus on issues of extractables and leachables (E&L) from packaging/delivery systems began during the mid-1990s. Since then, regulatory agency awareness of these issues has increased, while drug product formulations and other drug product contact materials have become more complex. When agency questions on extractables and leachables do arise, the process to evaluate them can seem overwhelming. As a result, many customers are asking: “Do I really need to complete all of the testing requested?”; “What does West already know about the elastomer formulation I am using?” or “Where do I start?”
English
Chinese
